key: cord-0888434-oyotu7t8
authors: Ahamad, Shahzaib; Kanipakam, Hema; Birla, Shweta; Ali, Md Shaukat; Gupta, Dinesh
title: Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M(pro) using molecular docking and dynamics simulations studies
date: 2020-10-24
journal: Eur J Pharmacol
DOI: 10.1016/j.ejphar.2020.173664
sha: 734890c21f6fccde54a99aafa1297110f02f8ff3
doc_id: 888434
cord_uid: oyotu7t8

Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Main protease (M(pro)) is one of the vital drug targets amongst all the coronaviruses, as the protein is indispensable for virus replication. The study aimed to identify promising lead molecules against M(pro) enzyme through virtual screening of Malaria Venture (MMV) Malaria Box (MB) comprising of 400 experimentally proven compounds. The binding affinities were studied using virtual screening based molecular docking which revealed five molecules having the highest affinity scores compared to the reference molecules. Utilizing the established 3D structure of M(pro) the binding affinity conformations of the docked complexes were studied by Molecular Dynamics (MD) simulations. The MD simulation trajectories were analysed to monitor protein deviation, relative fluctuation, atomic gyration, compactness covariance, residue-residue map and free energy landscapes. Based on the present study outcome, we propose three Malaria_box (MB) compounds, namely, MB_241, MB_250 and MB_266 to be the best lead compounds against M(pro) activity. The compounds may be evaluated for their inhibitory activities using experimental techniques.

COVID-19 pandemic is of great global public health concern triggering worldwide deaths, morbidity, disastrous socio-economic and political consequences too. The causative agent of COVID-19, the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) progresses as phases involving viral translation and replication as an initial phase followed by a second phase comprising of host inflammatory response (Siddiqi and Mehra, 2020) . Its successful human-to-human transmission by symptomatic as well as asymptomatic carriers has contributed in the rapid spread of the disease across the world (Ganyani et al., 2020; Mizumoto et al., 2020) . Rigorous research studies are being conducted to mitigate the effects of the viral infection by devising novel therapeutic strategies. Many studies on these agents have reported their mechanism of action targeting various aspects of viral life cycle including blocking of viral attachment, entry, hindering viral replication or survival in host cell or reducing exaggerated host immune response from (Fukao et al., 2007; Jo et al., 2020; Kruse, 2020; Wang et al., 2020; Yao et al., 2020) . The SARS-CoV-2 genome is the largest among all RNA-viruses, ranging from 27kb to 32kb, packed with a helical capsid. This structure is formed by a Nucleocapsid protein and RNA surrounded by an envelope. There are three structural proteins associated with this envelop namely membrane protein (M), envelope protein (E) and the spike protein (S). The structural proteins along with several viral proteases are mainly involved in replication, assembly and fusion. The S protein facilitates the entry of the virus in to human cells with the help of surface angiotensin-converting enzyme 2 (ACE2) receptor (Fig. 1) .

Owing to its important role in the viral life cycle and initiation of the virus pathophysiology, the main protease (M pro ) or chymotrypsin-like protease (3CLpro) has served as an attractive target for development of drugs directed against coronaviruses. The enzyme is required to cleave replicase polypeptide to generate various viral assembly facilitating proteins (Fig. 1) . The proteolytic processing mediated by M pro involves several cleavage sites, generating various non-structural proteins important for viral replication (Anand et al., 2003; Qamar) . It is a cysteine protease composed of three domains (I, II, III) and is conserved among all the coronaviruses (Dai et al., 2020) . Along with sharing many common features in different coronaviruses, M pro caters similar functions involving maturation of viral particles, capsid cleavage, polypeptide release, thereby occurrence of the infection (da Silva Hage-Melim et al., 2020) . Use of viral protease inhibitors to block the key proteases in order to prevent viral replication is one amongst the most-explored strategies being investigated against coronavirus . The basic strategy involves identification of the most active compounds which can inhibit the viral protease preventing disease progression (Hsu et al., 2005) . There are various groups conducting extensive research on drug repurposing (Agostini et al., 2018; Guy et al., 2020) or on identifying an effective inhibitor against the M pro Mengist et al., 2020; Zhang et al., 2020) .

Despite of the intensive research that has been going on, there are no effective drugs or vaccines for the pandemic till date.

In the present study we have used a comprehensive approach involving virtual screening based molecular docking and Molecular Dynamics (MD) simulations to identify potential M pro inhibitors from a pool of compounds present in Medicines for Malaria Venture (MMV) Malaria Box (MB) (Spangenberg et al., 2013) . The novelty in the present study is the use of MB database having 400 compounds which are chemically diverse, pharmacologically active and experimentally proven to inhibit the growth of Plasmodium parasites effectively (Duffy and Avery, 2012; Viswanadhan et al., 1989; Walters and Namchuk, 2003) . The 400 compounds, N3 inhibitor and Boceprevir drug (latter two as reference molecules) were subjected to virtual screening to evaluate its effective binding to the active cleft of M pro .

Based on the comparative analysis we prioritised five compounds namely MB_183, MB_241, MB_250, MB_266 and MB_380 from the MB dataset. The compounds were further subjected to MD simulations in comparison to reference molecules. The compounds were consequently analysed for ADME/T properties and were found to be potential drug-like candidates which can effectively bind the M pro enzyme. Furthermore, we analysed the conformational stability of the docked complexes using MD simulations with the help of various parameters such as Root Mean Square Deviation (RMSD), Root Mean Square J o u r n a l P r e -p r o o f

The work was carried out on High-performance computing (HPC) with 2 x 20 Cores Processors, 256 GB Ram; NVIDIA graphics card (GPU V100 32 GB); installed on an International Business Machines (IBM) server. The server is installed with various Bioinformatics Software such as GROMACS, Xmgrace and Schrödinger. Many offline and online Bioinformatics tools were applied in accomplishing the study.

Two reference molecules were used for all the subsequent analysis in the present study (Fig. 1) . The co-crystal structure of M pro embedded with N3 inhibitor (6LU7) and the structure bound with Boceprevir drug (6WNP) were retrieved from PDB database (Anson et al., 2020) and the molecules 3D structures were saved in PDB file format.

The M pro 4 digit PDB ID was given as input to identify the active site which gives significant insight to recognize surface structural pockets, shape and volume of every pocket, internal cavities of protein and surface areas. The active site and the interactive residues were selected using PDBsum and CASTp online tools (Laskowski et al., 2018; Tian et al., 2018) and also cross checked with literature sources such as PubMed (Anson et al., 2020; Liu et al., 2020) . The ligands 2D and 3D structures of the standard reference molecules N3 inhibitor and Boceprevir drug was collected from PDB. The ligands were prepared using AutoDock Tools (ADT) and the file was saved as pdbqt format (Trott and Olson, 2010) .

The 3D structure of M pro was prepared using the ADT protein preparation wizard. The polar hydrogen bonds and missing hydrogen atoms were added while water molecules and hetero-atoms were deleted (Forli et al., 2016) . The energy minimization was performed with default constraint of 0.3Å Root Mean Square (RMS) and charges were assigned. After protein preparation, clean structure was saved as a pdbqt file. The grid box of 126Å×126Å×126Å was generated around the centroid of inhibitor/drug compounds with assigned X, Y and Z axis.

J o u r n a l P r e -p r o o f

The ligand like subset of the MB database was utilized for the virtual screening to identify novel potential antagonist against M pro receptor. The pdbqt formatted files were provided as input along with standard reference molecules (N3 and Boceprevir) and 400 drug-like compound dataset of MB were screened against M pro (Duffy and Avery, 2012) . The top five compounds were ranked on the basis of the binding energy scores and the docking poses (Forli et al., 2016; Trott and Olson, 2010) . The compounds with favourable binding poses were identified with the help of lowest free energy were (∆G), defined as using the equation as follows,

where, (∆G complex ), (∆G receptor ) and (∆G ligand ) are the average values of Gibbs free energy for the complex, receptor and ligand, respectively.

The stability of the docked complex between the receptor-ligand exhibits more negative scores which reveal high potency of inhibitor. All the other docking parameters were kept default and the final visualization of the docked complexes was performed using PyMOL visualization tool (DeLano, 2002) . The active pocket of M pro and docked pose of N3, Boceprevir and the top best MB compounds were compared to find interactive orientations.

The detailed workflow followed in the study was presented in Fig. 1 .

The Absorption, Digestion, Metabolism, Excretion/ Toxicity (ADME/T) properties of the top five compounds from the virtual screening protocol were determined to evaluate druglikeness using QikProp module of Schrödinger commercial software (Schrödinger, 2012) .

Input zone comprises of a sketcher that helps the user to draw, edit and import the 2D structure. The output files can be saved as PDB formatted files which can be enabled in any visualization tools. The analysis provides major physiochemical properties such as flexibility, molecular weight/size, hydrophobicity, bioavailability, permeability and polar solubility (Daina et al., 2017; Lee et al., 2003) . The best screened compounds were further assessed to fulfil the Lipinski's rule of five violations to exhibit drug-likeliness (Lipinski, 2016) .

J o u r n a l P r e -p r o o f

MD simulations were executed for the best docked complexes with utmost binding affinity scores using GROMACS Version 5.18.3. Package (Abraham et al., 2015) . The topology of M pro was generated by using GROMOS9643a1 force field (Van Der Spoel et al., 2005) . Due to the lack of suitable force field parameters for drug like molecules in the GROMACS software, PRODRG server was used for generation of molecular topologies and coordinate files (Schüttelkopf and Van Aalten, 2004) . All the systems were solvated using simple point charge model (SPC/E) in a cubic box. To neutralize the system 0.15 M counter ions (Na + and Cl -) were added. The energy minimization of all the neutralized systems was performed using the steepest descent and conjugate gradients (50000 steps for each). The regulation of volume (NVT) and pressure (NPT) was run for system equilibration. Steepest descent followed by conjugate gradient algorithms was utilized on enzyme-ligand complexes.

The NVT ensemble at constant temperature of 300K and constant pressure of 1bar was employed. The SHAKE algorithm was used to confine the H atoms at their equilibrium distances, and periodic boundary conditions. Moreover, the Particle Mesh Ewald (PME) method used to define long-range electrostatic forces (Abraham et al., 2015) .The cut-offs for Van der Waals and columbic interactions were set at 1.0 nm. LINC algorithm was used to constrain the bonds and angles. Using the NPT ensemble, production runs were performed for the period of 100 ns, with time integration. The energy, velocity, and trajectory were The above mentioned parameters were calculated with the following equations:

Defined equation

Where, M=Σ i mi and r i (t) is the position of atom i at time t after least square fitting the structure to the reference structure. RMSF where, T is the time over which one wants to average and r i ref is the reference position of particle i. Rg

Where, mi is the mass of atom i and r i the position of atom i with respect to the center of mass of the molecule. SASA SASA = 4πR 2 *(Nacc /Ntot) Where, *Nacc and Ntot are the number of accessible and total number of points in the shell and where R is the sum of Van der Waal's radius.

PCA is one of the best techniques that help in reduction of complexity to extract the intensive motions in MD simulations analysis (Sang et al., 2017) . In this method a matrix was constituted for all the trajectories after excluding rotational and translational movements.

Herein, the essential dynamics protocol was implemented to calculate the eigenvectors and eigenvalues as well as their projections along the first two Principal Components (PC). By Diagonalising the matrix eigenvectors and eigenvalues were identified where, eigenvalues represent the amplitude of the eigenvector (Abdi and Williams, 2010) . The eigenvector of the matrix gives the multidimensional space and the displacement of atoms in the protein along each direction. In this process the essential subspace is created to know the movements of atom that are plotted by Cartesian trajectory coordinates using GROMACS utilities.

Based on the structural similarity with the inhibitors N3 and Boceprevir, a total of 400 experimentally proven compounds from the MB database were screened to obtain lead inhibitor. The five hits namely MB_183, MB_241, MB_250, MB_266 and MB_380 were prioritised based on estimated free binding energies and the docking poses in the active site of M pro . The five compounds were subjected to further analysis. The VS results yielded potential leads to inhibit M pro activity, showing highest docking scores in comparison to the reference molecules, suggested as structure-based design reference for coronaviruses. Many studies on coronaviruses have shown that the inhibitor N3 can specifically inhibit M pro , and has been reported to have potent antiviral activity (Ren et al., 2013; Wang et al., 2016; Xue et al., 2008; Yang et al., 2005) . Similarly, another study reported 3D structural similarity with Hepatitis C virus (HCV) NS3/4A protease to the SARS-CoV2 M pro protease particularly at the key active site residues arrangement (Bafna et al., 2020) . Boceprevir, a drug to treat HCV have been shown to have broad-spectrum antiviral activity and its structural scaffolds have the potential to be rapidly optimized into potential anti SARS-CoV-2 compounds (Anson et al., 2020) .

The N3, Boceprevir and the five MB compounds were docked with M pro with the assistance of AutoDock vina standalone suite. After successful docking experiments the significant binding and the lowest energy conformations with M pro were evaluated for further elucidation. The colour molecular graphics were plotted using PyMOL visualization tool where, the ligands are represented as ball and stick model, whereas M pro is shown in cartoon mode ( Fig. 2A-G) . The amino acid residues interacting with the receptor are shown as line model and the H-bond formation as red dashed lines between the receptor-ligand complexes.

The substrate-binding site of M pro lies between the domains I and II spanning the residues from 10 to 99 and 100 to 182, respectively, whereas the domain III, a globular cluster of five helices starts from residues 198 to 303 is involved in regulating the M pro dimerization . There lies a crucial catalytic dyad formed by the conserved residues His41 and Cys145. In the analysis, the residues Thr24, Thr25, His41, Thr45, Ser46, Met49, Tyr54, Phe140, Leu141, Asn142, Gly143, Ser144, Cys145, His163, His164, Glu166, J o u r n a l P r e -p r o o f Leu167 and Gln189 are found to interact with all the five MB screened compounds. The interaction details of each complex are mentioned below.

The docking results of M pro -N3 complex formed 5 H-bonds with Asn142, Gly143, Glu166, Leu167 and Gln189, forming stable confirmations ( Fig. 2A) . Additionally, the residues Thr24, Thr25, Thr26, Leu27, His41, Met49, Tyr51, Phe140, Leu141, Ser144, Cys145, His163, His164, Pro168, His172, Arg186, Asp187, Thr190, Ala191 and Gln192 provided the stability to the M pro -N3 complex along with several Van der Waal's interactions (Fig. 3A) . The complex M pro -Boceprevir at the interactive site revealed formation of 5 Hbonds with residues His41, Met49, Tyr54, Gly143 and His164 (Fig. 2B) , and the residues His14, Thr25, Thr26, Leu27, Cys44, Leu50, Pro52, Leu141, Asn142, Ser144, Cys145

Met165, Glu166, Val186, Asp187, Arg188, Gln189, Thr190, Gln192 were involved in Van der Waal interactions (Fig. 3B) . The docking scores of both the complexes were estimated to be -8.3 kcal/mol and -6.8kcal/mol, respectively (Table 1 and Supplementary Table S2 ).

The binding affinity of compound MB_183 towards the M pro active site is characterized by an H-bond with Asn142 (Fig. 2C) . The complex was stabilized with a greater docking score than the standard reference compounds with -7.4 kcal/mol (Table 1) .

The other amino acid residues like Thr25, Thr26, Leu27, His41, Met49, Leu141, Gly143, Ser144, Cys145, His164, Met165, Glu166, Arg188, Gln189 and Thr190 were involved in hydrophobic interactions (Fig. 3C) .

The interaction between the M pro -MB_241 docked complex shows 3 H-bonds with the residues Leu141, Ser144 and Glu166 (Fig. 2D) . Additionally, the residues His41, Cys145, Ser144, Gly143, Asn142, Phe140, His172, His163, His164, Met165, Glu166, Leu167, Pro168, Val186, Arg188, Gln189, Thr190, Ala191 and Gln192 are involved in hydrophobic and Van der Waal's interactions, stabilizing the receptor-ligand complex (Fig. 3D) . The binding energy score of the complex was found -7.6 kcal/mol, comparable with N3 and Boceprevir complexes (Table 1) .

The molecular docking experiment of MB_250 towards the M pro active pocket was stabilized with the formation of 3 H-bonds by residues His41, Leu141 and His163, respectively (Fig. 2E) . Apart from H-bond formation, the residues Thr25, Thr26, Leu27, Met49, Tyr54, Tyr118, Phe140, Asn142, Gly143, Ser144, Cys145, His164, Glu166, Met165, His172, Val186, Asp187, Arg188, Gln189, Thr190 and Gln192 are seen in the 4Ǻ region around the active site sharing similar binding with the reference molecules (Fig. 3E) . The M pro -MB_250 docking complex was defined with highest docking energy of -8.8 kcal/mol (Table 1) .

The affinity of M pro -MB_266 complex revealed that it fits in the active site of the reference compounds N3 and Boceprevir. The binding orientation of the docked complex was stabilized with a binding score of -8.9 kcal/mol ( Table 1) . The stabilization was further strengthened with the formation of 6 H-bonds with the residues Thr24, Thr25, Thr45, Ser46, Phe140 and Asn142 headed for M pro receptor (Fig. 2F) . The residues Cys22, Thr26, Leu27, His41, Cys44, Met49, Leu141, Gly143, Ser144, Cys145, His163, His164, Met165, Glu166, His172 and Gln189 were actively involved in the Van der Waal's interaction (Fig. 3F) .

The molecular docking results estimated that the complex M pro -MB_380 interact at the active site cavity, stabilized with 5 H-bonds with the residues Thr24, Thr25, Ser46, Asn142 and Gln189 (Fig. 2G) . The additional residues, Cys22, Thr24, Thr26, Leu27, His41, Val42, Ile43, Cys44, Glu47, Met49, Leu50, Asn51, Phe140, Leu141, Gly143, Ser144, Cys145, His163, His164, Met165, Glu166, Leu167, Pro168, Thr169, Gly170, His172, Ala173, Arg188, Ala191 and Gln192 are involved in hydrophobic interactions, Van der Waal's interactions and other contacts are depicted in the 2D plot (Fig. 3G) . The docking energy is -9.2 kcal/mol for the complex, sharing similar binding pose with that of the reference compounds (Table 1 ).

In the present analysis, it was evident that the shortlisted compounds-MB_183, (Table 2A&2B ) (Lee et al., 2003; Lipinski, 2016) .

The compounds were further examined for the Lipinski rule of five parameters including molecular weight (396 to 469), Hydrogen bond Acceptor (8.7 to 14.8),

Hydrogen bond donor (4 to 10), RO5 (0 to 3) and surface polar atoms (76 to 134). The values for the mentioned parameters were estimated to look for the presence of drug-like properties (Lipinski, 2016) . Out of all, the four compounds namely MB_183, MB_241, MB_250, and MB_266 expect MB_380 fitted with the Lipinski's properties exhibiting drug-likeness there by having good absorption in the biological systems (Table 2A) . Table 2 . ADME/T properties of the ligands in comparison to reference molecules, interpreting pharmacological parameters and Lipinski's rule predicted using QikProp module of Schrödinger. 

To 

The docked complexes were subjected to RMSD analysis to assess the residual flexibility of M pro . The native protein, MB_241, MB_250, MB_266 and MB_380 noticeably showed steady RMSD of ∼0.4nm except MB_183 which showed slightly higher RMSD of ∼0.5nm. The N3 and Boceprevir showed RMSD of ∼0.3nm, respectively (Fig. 4A) .The

Probability Distribution Function (PDF) analysis revealed that the native protein was stable with a threshold of 0.38nm of average RMSD (Supplementary Table 1 

The compactness of the receptor-docked complexes was evaluated by calculation of radius of gyration (Rg). The results showed that the Rg values of the native protein; and the complexes with N3, Boceprevir and five MB compounds remained stable with a range between ∼2.4nm to ∼2.13nm throughout the MD simulation frame of 100ns (Fig. 5A) (Supplementary Table 1 and 2.13nm, respectively (Fig. 5B) . The comparative Rg results revealed stable folding behaviour of M pro after binding with MB_241, MB_250, MB_266 compounds indicating high compactness between the complexes than that of reference molecules. This suggests that the MB compounds stayed strongly bound to the active site and they helped to maintain the stability and compactness of the protein structure better than the reference molecules.

Additionally, we also performed a SASA analysis to understand the solvent behaviour of all the complexes (Supplementary Table 1 ). SASA profiles revealed that the docked complexes had average values with a range of 170nm 2 -173nm 2 (Fig. 5C) 172.95nm 2 and 172.51nm 2 respectively (Fig. 5D) . The results showed that the compounds MB_241, MB_250 and MB_266 possessed stable hydrophobic contacts between the receptor and ligand complexes, similar to the reference molecules which make the maximum region of M pro enzyme accessible to the solvent molecules.

To understand the binding affinity of MB compounds towards M pro , the MD trajectories were analysed for hydrogen bond monitoring to calculate the total number of bonds formed between the receptor-ligand complexes. The MB_183, MB_241, MB_250, MB_266 and MB_380 docked complexes showed the number of hydrogen bonds to be between 0-5, 0-4, 0-5, 0-8 and 0-7, respectively (Fig. 6A-E) . Consequently, the M pro -N3 and M pro -Boceprevir docked complexes revealed the number of H-bonds to be between 0-10 and 0-6 respectively (Fig. 6F&6G) . We observed maximum number of hydrogen bonds in the MB_266-M pro complex indicating significant interaction lying between the two references.

Overall, the hydrogen bonds and hydrophobic interactions revealed that the complexes MB_241, MB_250 and MB_266 were highly stabilizing the active pocket of M pro J o u r n a l P r e -p r o o f (Supplementary Table 2 ). The results also suggested that the number of hydrogen bonds formed were steady throughout the simulations for all the three docked complexes. The amino acid residues present in the active site are also persistent and contribute to the stability of the overall M pro geometry throughout the total simulation time accordance to the reference molecules.

The conformational subspace of the complexes was evaluated using PCA to understand the dynamic behaviour of M pro . The PCA analysis revealed that the conformational clusters are well defined and the five compounds covered minimum subspaces (Fig. 6H) . The graph was plotted between the two eigenvector 1 and 2 which gave the displacement of atomic fluctuation and type of motion obtained between the complexes.

The eigenvector values of the docked complexes MB_183, MB_241, MB_250, MB_266 and MB_380 are in the ranges of ∼-4nm 2 to ∼5nm 2 and ∼-8nm 2 to ∼5nm 2 , respectively, in comparison to the native protein and reference molecules ( Supplementary Fig. 1) . Among all the five compounds, the complex of MB_241 showed eigenvector 1 in the range -2nm 2 to -2.5nm 2 , and eigenvector 2 in the range -4nm 2 to 5nm 2 of minimum cluster, MB_250 showed eigenvector 1 and 2 in the range -2.5nm 2 to -3nm 2 and -2nm 2 to 3.5nm 2 of range and MB_266 occupied small range occupancy cluster range with eigenvector 1 and 2 in the range of -3nm 2 to 3nm 2 and -4nm 2 to 2nm 2 respectively. The proposed three docked complexes MB_241, MB_250, MB_266 showed restricted space in complex with M pro , leading to well-defined internal motion behaviour vital for the complex stabilization better than the N3 and Boceprevir inhibitors.

The Fig. 2) Fig. 3) . The global free energy minima results showed that the docked complexes revealed steady states on the folding behaviour of M pro than the reference molecules. The overall analysis revealed that the complexes were persistent with high energy minima suggesting the amino acids between the docking poses are vital for stability and function of M pro enzyme. Further investigation was performed to know the atomic density distribution of the complexes for atomic orientation towards M pro .

The results elucidated a stable density area values for native protein, MB_183, MB_241, MB_250, MB_266, MB_380, N3 inhibitor and Boceprevir ranging from 2.39nm -3 , 2.52nm -3 , 3.53nm -3 , 3.28nm -3 , 3.78nm -3 , 2.99nm -3 , 3.65nm -3 and 3.17nm -3 , respectively (Fig. 7A-7H) .

From the analysis it was shown that the density area of each atom in the complexes MB_241, MB_250, MB_266 were found to be in stable distribution and energy wells showed that all the compounds were sharing similar binding patterns alike N3 and Boceprevir for M pro indicating that the complexes are binding to the same active pocket.

RRCM (Dorosh and Stepanova, 2017; Shao, 2020) is examined to calculate the smallest distance between Cα-atoms of amino acid residues that conjugate enzyme-ligand docked complexes that influence secondary structure elements to know the allosteric effect on M pro . The RRCM of native and docked complexes namely MB_183, MB_241, MB_250, MB_266, MB_380, N3 inhibitor and Boceprevir exposed the atomic distance of 5.28nm, 5.55nm, 5.57nm, 5.65nm, 5.53nm, 5.76nm, 5.54nm and 5.42nm, respectively. From the above comparative analysis, it is evident that the interacting aminoacids of the complexes were in close proximity to tender a strong binding, affirming stable conformations of the ligands towards the active pocket of M pro in accordance to the reference molecules.

J o u r n a l P r e -p r o o f Furthermore, PCA of the covariance matrix between the proposed two system complexes projected well-defined clusters than the reference complexes revealing higher compactness towards the Cα-atomic positional fluctuations of M pro . The FEL analysis portrayed that the three complexes MB_241, MB_250 and MB_266 were having a stable distribution of energy J o u r n a l P r e -p r o o f wells headed for M pro . The residue-residue contacts map was also validated and found that the complexes' interactive amino acids are highly responsible for maintaining conformational stability and proximity, affirming the importance of allosteric effects on M pro . Therefore, it is evident that the three proposed compounds MB_241, MB_250, MB_266 with greater binding affinity, conformational stability and pharmacological properties indicated a strong fit into the active pocket of M pro , suggesting better ability to block the substrate-binding site, thereby probably hindering the targeted process of viral replication.

In the present study, we used pharmacoinformatic techniques to identify potential inhibitors of SARS-CoV-2 M pro . Summarily, we carried out virtual screening, drug-likeliness and MD simulations to identify best lead compounds amongst the Malaria Box compound library. Virtual screening based molecular docking protocol was carried out to select compounds capable of binding to M pro active site, which helped to shortlist five compounds.

The five compounds were checked further with various methods like Lipinski's rule of five and ADME/T parameters to get the probable drug like candidates. Moreover, the In Silico toxicity evaluation showed the compounds to be of low risk and possess various pharmacological properties. Furthermore, the RMSD, RMSF, hydrogen bonds and free energy wells analysis during MD simulations indicated three MB compounds to be in more stable binding with SARS-CoV-2 M pro . This indicated that the three compounds, namely MB_241, MB_250 and MB_266 are better than the rest of the two compounds, which may be used for further exploration. 

Principal component analysis

GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease

Designing of phenol-based β− carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach

2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs

Structural Similarity of SARS-CoV2 Mpro and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as

Emerging coronaviruses: genome structure, replication, and pathogenesis

Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19

Structurebased design of antiviral drug candidates targeting the SARS-CoV-2 main protease

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

Pymol: An open-source molecular graphics tool

Probing oligomerization of amyloid beta peptide in silico

Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening

Computational protein-ligand docking and virtual drug screening with the AutoDock suite

An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling

Estimating the generation interval for COVID-19 based on symptom onset data

Rapid repurposing of drugs for COVID-19

Mechanism of the maturation process of SARS-CoV 3CL protease

Structure of M pro from SARS-CoV-2 and discovery of its inhibitors

Inhibition of SARS-CoV 3CL protease by flavonoids

Structural and functional alterations of nitric oxide synthase 3 due to missense variants associate with high-altitude pulmonary edema through dynamic study

Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China

PDBsum: Structural summaries of PDB entries

The PreADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties. EuroQSAR designing drugs and crop protectants: processes, problems and solutions

Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions

The crystal structure of COVID-19 main protease in complex with an inhibitor N3

Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M pro

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants

The newly emerged SARS-like coronavirus HCoV-EMC also has an" Achilles' heel": current effective inhibitor targeting a 3C-like protease

Parametric functional principal component analysis

QikProp, version 3.5

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes

Effect of conjugated (EK) 10 peptide on structural and dynamic properties of ubiquitin protein: a molecular dynamics simulation study

COVID-19 illness in native and immunosuppressed states: A clinicaltherapeutic staging proposal

The open access malaria box: a drug discovery catalyst for neglected diseases

CASTp 3.0: computed atlas of surface topography of proteins

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

GROMACS: fast, flexible, and free

Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics

Designing screens: how to make your hits a hit

Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design

Design of wide-spectrum inhibitors targeting coronavirus main proteases

In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved αketoamide inhibitors